Your browser doesn't support javascript.
loading
Management of Vertebral Fragility Fracture in Older People: Recommendations from a Spanish Consensus of Experts.
Castañeda, Santos; Navarro Ceballos, Carmen; Usón Jaeger, Jaqueline; de Miguel Benadiba, Carolina; Gómez Martín, Esteban; Martínez Díaz-Guerra, Guillermo; Alvarez-Galovich, Luis.
Afiliación
  • Castañeda S; Rheumatology Service, Hospital Universitario La Princesa, IIS-Princesa, 28006 Madrid, Spain.
  • Navarro Ceballos C; Cátedra UAM-Roche, EPID-Future, Department of Medicine, Autonomous University of Madrid (UAM), 28049 Madrid, Spain.
  • Usón Jaeger J; Geriatric Service, Hospital Universitario Severo Ochoa, Leganés, 28914 Madrid, Spain.
  • de Miguel Benadiba C; Rheumatology Service, Hospital General Universitario de Móstoles, Móstoles, 28935 Madrid, Spain.
  • Gómez Martín E; Rehabilitation Service, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Martínez Díaz-Guerra G; Primary Care Center Zulema, Alcalá de Henares, 28810 Madrid, Spain.
  • Alvarez-Galovich L; Endocrinology Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Geriatrics (Basel) ; 9(2)2024 Feb 23.
Article en En | MEDLINE | ID: mdl-38525741
ABSTRACT
Vertebral fragility fractures (VFF) pose a challenge for appropriate care. The aim of this study was to develop consensus recommendations for the management of VFF in older people from a multidisciplinary approach. Specialists in osteoporosis belonging to different scientific societies reviewed the main clinical practice guidelines published in Spain in 2014. Thirty-five recommendations for the management of VFF were evaluated by seven experts using an anonymous survey. Consensus was defined as 80% of responses of 8 (agree) and 9 (strongly agree) on a Likert scale. Consensus was achieved in 22 recommendations (62.8%). The experts agreed on the need for anamnesis, clinical assessment, and laboratory tests, including erythrocyte sedimentation rate, proteinography, and the assessment of levels of calcium, vitamin D, alkaline phosphatase, and thyroid-stimulating hormone. Optional tests, such as bone turnover markers (BTMs), magnetic resonance imaging, bone scintigraphy, or using a fracture risk assessment tool (FRAX®), did not achieve an agreed consensus. Also, there was consensus regarding the administration of calcium/vitamin D supplements, the withdrawal of toxic habits, and personalized physical exercise. Participants agreed on the administration of teriparatide for 24 months and then a switch to denosumab or bisphosphonates in patients at high risk of fracture. Specialists in osteoporosis, primary care physicians, and geriatricians should be involved in the follow-up of patients with VFF. Although there was multidisciplinary agreement on diagnostic tests and non-pharmacological and pharmacological treatment in frail older people, therapeutic objectives should be individualized for every patient. In addition to the specific recommendations, close collaboration between the geriatrician and the primary care physician is essential for the optimal chronic management of frail patients with fragility fractures.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Geriatrics (Basel) Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Geriatrics (Basel) Año: 2024 Tipo del documento: Article País de afiliación: España